Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous CarcinomaFlurina A.M. Saner, Jennifer M. Koziak, Dinuka Ariyaratne et al.|Clinical Cancer Research|2024Cited by 14
Concurrent RB1 loss and <i>BRCA</i> -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinomaFlurina A.M. Saner, Jennifer M. Koziak, Kazuaki Takahashi et al.|medRxiv|2023Cited by 5